Nabumetone Tablet
Product Images NDC 63629-8506

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nabumetone (NDC 63629-8506). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

This is a table displaying the plasma concentrations of Nabumetone Active Metabolite (BMNA) at steady state after administering Nabumetone once a day to two different groups of participants. One group took 1000 mg (31 participants), and the other group took 2000 mg (12 participants). The table includes time measured in hours on the X-axis and concentrations measured in unspecified units on the Y-axis.*

FDA Label Image

Label (Lbl636298506)

This is the description of nabumetone tablets, a medication used to relieve pain caused by arthritis, ankylosing spondylitis, and other conditions. It contains 500 mg of Nabumetone USP per tablet and should be kept out of reach of children. The tablets should be stored at a temperature between 20° to 25°C. Dispense in a tightly sealed, light-resistant container with a child-resistant closure. The NDC number is 63629-8506-1, and these tablets are only available with a prescription.*

FDA Label Image

Structure1 (Structure1)

FDA Label Image

Structure2 (Structure2)

The text describes the name of a chemical compound, 6-methoxy-2-naphthylacetic acid (SMNA), and lists two molecular formulas for it: COOH and CHgO.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.